‘An important milestone:’ Canada approves expensive new drug that can slow Alzheimer’s disease
October 27, 2025
October 27, 2025
An expensive new drug that can slow the progression of Alzheimer’s disease was approved by Health Canada on Friday.
While existing medications treat Alzheimer’s symptoms, lecanemab is the first drug authorized in Canada that targets the disease’s underlying cause in order to reduce the rate of cognitive and functional decline.
“This is an important milestone,” neurologist Dr. Sharon Cohen told CTVNews.ca. “What this does is slow down the disease at an early stage where people are still living at home and functioning quite well.”
Cohen, who was involved in clinical trials of the drug, is the medical director of the Toronto Memory Program, a clinic that specializes in the diagnosis and treatment of Alzheimer’s and related disorders.
“If you think about the treatments we’ve had so far for Alzheimer’s disease, they’ve been directed at the dementia stage of the disease, where people are already dependent,” Cohen explained by phone on Monday. “Now we have something that goes much earlier in the disease … this is a big deal.”
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.